Jefferson University hospital

Philadelphia, Pennsylvania 19107

1 studies enrolling now · 11 studies all time

What they study most

Antibody-mediated Rejection, Cystic Fibrosis, Deep Venous Thromboses, Desmoid, Desmoid Tumor, Heart Failure, Heart Failure With Preserved Ejection Fraction, Infectious Pneumonia, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV

Studies at this site

• A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours — Recruiting now
• Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction — Recruiting now
• A Study of AL102 in Patients With Progressing Desmoid Tumors — Running, not enrolling
• Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia — Stopped early
• TRANSFORM-HF: ToRsemide compArisoN With furoSemide FORManagement of Heart Failure — Completed
• Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients — Stopped early
• ThRombosis ExclUsion STudy — Stopped early
• Observational Study Comparing Home to Office Spirometry — Completed
• Phase 2b Study in NASH to Assess IVA337 — Completed
• Phase 3 Study of Oral Ibrexafungerp (SCY-078) Vs. Placebo in Subjects With Recurrent Vulvovaginal Candidiasis (VVC) — Completed
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early